Literature DB >> 6650083

An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis.

M Fjälling, A Dackenberg, I Hedman, L E Tisell.   

Abstract

It is well established that external radiation to the neck area can act as an initiating factor in the development of hyperparathyroidism (HPT). In the present work the incidence of HPT was studied in a series of 125 patients treated with 131I for thyrotoxicosis and in untreated controls matched for age and sex. No increased incidence of HPT was found among the radioiodine treated patients. The time from treatment to follow-up was 21 years on the average. The most probable reason for the lack of an effect on the HPT-incidence is that variable and mostly low doses of radiation with low dose rates are absorbed in the parathyroids after 131I-treatment for thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6650083

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  3 in total

1.  Radioiodine-associated thyroid cancers.

Authors:  S Tezelman; R F Grossman; A E Siperstein; O H Clark
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

Review 2.  Graves disease in childhood: a review of the options for diagnosis and treatment.

Authors:  Jorg Dötsch; Wolfgang Rascher; Helmuth G Dörr
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

3.  Hyperparathyroidism two years after radioactive iodine therapy in an adolescent male.

Authors:  Danielle L Gomez; Dorothy I Shulman
Journal:  Case Rep Pediatr       Date:  2014-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.